On 15 March 2019 the Committee for Risk Assessment (RAC) of the European Chemicals Agency (ECHA) adopted an opinion recommending to classify flumioxazin as toxic for reproduction category 2. Following discussion with the Member States in the Standing Committee on Plants, Animals, Food and Feed in July 2019, the Commission mandated the Authority to update its Conclusion on flumioxazin with regard to endocrine disrupting properties according to the criteria laid down in points 3.6.5 and 3.8.2 of Annex II to Regulation (EC) No 1107/2009, as amended by Commission Regulation (EU) 2018/605 [Commission Regulation (EU) 2018/605 of 19 April 2018 amending Annex II to Regulation (EC) No 1107/2009 by setting out scientific criteria for the determination of endocrine disrupting properties (OJ L 101, 20.4.2018, p. 33).].
Recital 10, Regulation (EU) 2022/43
In forcesince 13 Jan 2022